Spontaneous regression of low-grade cervical intraepithelial lesions is positively improved by topical bovine colostrum preparations (GINEDIE®). A multicentre, observational, Italian pilot study

C. Stefani, C. A. Liverani, V. Bianco, C. Penna, T. Guarnieri, C. Comparetto, E. Monti, I. Valente, A. L. Pieralli, C. Fiaschi, M. Origoni

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

OBJECTIVES: Human papillomavirus (HPV) is the causal agent of cervical cancer. The great majority of abnormal Pap test results-almost 90%-is referrable to either atypical squamous intraepithelial lesion or CIN1. For these lesions, worldwide agreement exists concerning the high rate-ranging from 40% to 70%-of spontaneous regression over a period of 1-5 years. Host's immune response is a key point influencing the natural history of these conditions. Bovine colostrum is a natural agent positively promoting several immune activities against bacterial and viral agents. The aim of this report was to evaluate the potential positive effect of bovine colostrum-containing vaginal tablets administered to CIN1 diagnosed patients in a prospective trial in regards to spontaneous regression rate. PATIENTS AND METHODS: A series of 256 consecutive patients with histologically proven CIN1 recruited in a multicentre, observational, Italian study. Patients have been enrolled in a 24-weeks protocol of treatment and re-tested at the end of the study. Rates of regression have been recorded. RESULTS: Overall regression rate to a negative histology at the end of the 6 month follow up was 75.5%. CONCLUSIONS: Regression to normal histology was observed in a very high rate of cases in a very short period compared to the natural history of these lesions. CIN1 patients could benefit from bovine colostrum topical administration in terms of significantly shortening the regression time.

Original languageEnglish
Pages (from-to)728-733
Number of pages6
JournalEuropean Review for Medical and Pharmacological Sciences
Volume18
Issue number5
Publication statusPublished - 2014

Fingerprint

Colostrum
Natural History
Histology
Foams and Jellies Vaginal Creams
Papanicolaou Test
Topical Administration
Clinical Protocols
Uterine Cervical Neoplasms
Observational Studies

Keywords

  • Bovine colostrum
  • CIN1
  • HPV
  • Human Papillomavirus
  • Immunomodulation
  • Low-grade CIN
  • Natural history
  • Regression

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology (medical)

Cite this

Spontaneous regression of low-grade cervical intraepithelial lesions is positively improved by topical bovine colostrum preparations (GINEDIE®). A multicentre, observational, Italian pilot study. / Stefani, C.; Liverani, C. A.; Bianco, V.; Penna, C.; Guarnieri, T.; Comparetto, C.; Monti, E.; Valente, I.; Pieralli, A. L.; Fiaschi, C.; Origoni, M.

In: European Review for Medical and Pharmacological Sciences, Vol. 18, No. 5, 2014, p. 728-733.

Research output: Contribution to journalArticle

Stefani, C. ; Liverani, C. A. ; Bianco, V. ; Penna, C. ; Guarnieri, T. ; Comparetto, C. ; Monti, E. ; Valente, I. ; Pieralli, A. L. ; Fiaschi, C. ; Origoni, M. / Spontaneous regression of low-grade cervical intraepithelial lesions is positively improved by topical bovine colostrum preparations (GINEDIE®). A multicentre, observational, Italian pilot study. In: European Review for Medical and Pharmacological Sciences. 2014 ; Vol. 18, No. 5. pp. 728-733.
@article{f612914b3bfe4b2ebb39fb4b92243c96,
title = "Spontaneous regression of low-grade cervical intraepithelial lesions is positively improved by topical bovine colostrum preparations (GINEDIE{\circledR}). A multicentre, observational, Italian pilot study",
abstract = "OBJECTIVES: Human papillomavirus (HPV) is the causal agent of cervical cancer. The great majority of abnormal Pap test results-almost 90{\%}-is referrable to either atypical squamous intraepithelial lesion or CIN1. For these lesions, worldwide agreement exists concerning the high rate-ranging from 40{\%} to 70{\%}-of spontaneous regression over a period of 1-5 years. Host's immune response is a key point influencing the natural history of these conditions. Bovine colostrum is a natural agent positively promoting several immune activities against bacterial and viral agents. The aim of this report was to evaluate the potential positive effect of bovine colostrum-containing vaginal tablets administered to CIN1 diagnosed patients in a prospective trial in regards to spontaneous regression rate. PATIENTS AND METHODS: A series of 256 consecutive patients with histologically proven CIN1 recruited in a multicentre, observational, Italian study. Patients have been enrolled in a 24-weeks protocol of treatment and re-tested at the end of the study. Rates of regression have been recorded. RESULTS: Overall regression rate to a negative histology at the end of the 6 month follow up was 75.5{\%}. CONCLUSIONS: Regression to normal histology was observed in a very high rate of cases in a very short period compared to the natural history of these lesions. CIN1 patients could benefit from bovine colostrum topical administration in terms of significantly shortening the regression time.",
keywords = "Bovine colostrum, CIN1, HPV, Human Papillomavirus, Immunomodulation, Low-grade CIN, Natural history, Regression",
author = "C. Stefani and Liverani, {C. A.} and V. Bianco and C. Penna and T. Guarnieri and C. Comparetto and E. Monti and I. Valente and Pieralli, {A. L.} and C. Fiaschi and M. Origoni",
year = "2014",
language = "English",
volume = "18",
pages = "728--733",
journal = "European Review for Medical and Pharmacological Sciences",
issn = "1128-3602",
publisher = "Verduci Editore",
number = "5",

}

TY - JOUR

T1 - Spontaneous regression of low-grade cervical intraepithelial lesions is positively improved by topical bovine colostrum preparations (GINEDIE®). A multicentre, observational, Italian pilot study

AU - Stefani, C.

AU - Liverani, C. A.

AU - Bianco, V.

AU - Penna, C.

AU - Guarnieri, T.

AU - Comparetto, C.

AU - Monti, E.

AU - Valente, I.

AU - Pieralli, A. L.

AU - Fiaschi, C.

AU - Origoni, M.

PY - 2014

Y1 - 2014

N2 - OBJECTIVES: Human papillomavirus (HPV) is the causal agent of cervical cancer. The great majority of abnormal Pap test results-almost 90%-is referrable to either atypical squamous intraepithelial lesion or CIN1. For these lesions, worldwide agreement exists concerning the high rate-ranging from 40% to 70%-of spontaneous regression over a period of 1-5 years. Host's immune response is a key point influencing the natural history of these conditions. Bovine colostrum is a natural agent positively promoting several immune activities against bacterial and viral agents. The aim of this report was to evaluate the potential positive effect of bovine colostrum-containing vaginal tablets administered to CIN1 diagnosed patients in a prospective trial in regards to spontaneous regression rate. PATIENTS AND METHODS: A series of 256 consecutive patients with histologically proven CIN1 recruited in a multicentre, observational, Italian study. Patients have been enrolled in a 24-weeks protocol of treatment and re-tested at the end of the study. Rates of regression have been recorded. RESULTS: Overall regression rate to a negative histology at the end of the 6 month follow up was 75.5%. CONCLUSIONS: Regression to normal histology was observed in a very high rate of cases in a very short period compared to the natural history of these lesions. CIN1 patients could benefit from bovine colostrum topical administration in terms of significantly shortening the regression time.

AB - OBJECTIVES: Human papillomavirus (HPV) is the causal agent of cervical cancer. The great majority of abnormal Pap test results-almost 90%-is referrable to either atypical squamous intraepithelial lesion or CIN1. For these lesions, worldwide agreement exists concerning the high rate-ranging from 40% to 70%-of spontaneous regression over a period of 1-5 years. Host's immune response is a key point influencing the natural history of these conditions. Bovine colostrum is a natural agent positively promoting several immune activities against bacterial and viral agents. The aim of this report was to evaluate the potential positive effect of bovine colostrum-containing vaginal tablets administered to CIN1 diagnosed patients in a prospective trial in regards to spontaneous regression rate. PATIENTS AND METHODS: A series of 256 consecutive patients with histologically proven CIN1 recruited in a multicentre, observational, Italian study. Patients have been enrolled in a 24-weeks protocol of treatment and re-tested at the end of the study. Rates of regression have been recorded. RESULTS: Overall regression rate to a negative histology at the end of the 6 month follow up was 75.5%. CONCLUSIONS: Regression to normal histology was observed in a very high rate of cases in a very short period compared to the natural history of these lesions. CIN1 patients could benefit from bovine colostrum topical administration in terms of significantly shortening the regression time.

KW - Bovine colostrum

KW - CIN1

KW - HPV

KW - Human Papillomavirus

KW - Immunomodulation

KW - Low-grade CIN

KW - Natural history

KW - Regression

UR - http://www.scopus.com/inward/record.url?scp=84896937615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896937615&partnerID=8YFLogxK

M3 - Article

C2 - 24668716

AN - SCOPUS:84896937615

VL - 18

SP - 728

EP - 733

JO - European Review for Medical and Pharmacological Sciences

JF - European Review for Medical and Pharmacological Sciences

SN - 1128-3602

IS - 5

ER -